1. Home
  2. LQDA vs PAGS Comparison

LQDA vs PAGS Comparison

Compare LQDA & PAGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LQDA

Liquidia Corporation

HOLD

Current Price

$39.41

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

PAGS

PagSeguro Digital Ltd.

HOLD

Current Price

$11.26

Market Cap

2.7B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
LQDA
PAGS
Founded
2004
2006
Country
United States
Brazil
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.7B
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
LQDA
PAGS
Price
$39.41
$11.26
Analyst Decision
Strong Buy
Buy
Analyst Count
11
7
Target Price
$41.00
$11.71
AVG Volume (30 Days)
964.7K
3.2M
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
1.21%
EPS Growth
51.81
N/A
EPS
N/A
N/A
Revenue
$158,320,000.00
N/A
Revenue This Year
$278.87
$11.14
Revenue Next Year
$57.13
$7.19
P/E Ratio
N/A
$7.74
Revenue Growth
1031.18
N/A
52 Week Low
$11.85
$7.74
52 Week High
$46.67
$12.32

Technical Indicators

Market Signals
Indicator
LQDA
PAGS
Relative Strength Index (RSI) 55.54 62.19
Support Level $31.75 $9.21
Resistance Level $46.67 $12.32
Average True Range (ATR) 2.01 0.41
MACD 0.27 0.14
Stochastic Oscillator 62.95 74.94

Price Performance

Historical Comparison
LQDA
PAGS

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

About PAGS PagSeguro Digital Ltd.

PagSeguro Digital Ltd is a Brazilian-based company that acts as a provider of financial technology solutions focused on Micro-Merchants, Small Companies and Medium-Sized Companies (SMEs), in Brazil. The company provides a range of solutions and tools such as cash-in and cash-out options and provides access to working capital to help to manage its cash flow. It delivers an end-to-end digital ecosystem to address day-to-day financial needs, including receiving and spending funds and managing and growing businesses for clients. The company also offers the Free PagSeguro Digital Account delivering Cash-In Solutions, Online and In-Person Payment Tools, Online Payment Tools; and Web Check Outs offer tokenization, handling of shipping information, and others.

Share on Social Networks: